These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31559543)

  • 1. ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.
    Newhook TE; Tzeng CD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):749-750. PubMed ID: 31559543
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Hilal T; Patel BK
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Transoral Robotic Surgery Combined with Neoadjuvant Chemotherapy for Management of Advanced Laryngohypopharyngeal Cancer.
    Park YM; Kim SH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):894-895. PubMed ID: 30288650
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients.
    van der Noordaa MEM; Vrancken Peeters MTFD
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):677-678. PubMed ID: 30474766
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Prognostic Role of Pathologic Complete Response After Neoadjuvant Therapy in Digestive Cancer.
    Wan T; Zhou YM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):587. PubMed ID: 31011901
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?
    Kantor O; Yao K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):650-651. PubMed ID: 30327968
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Reducing Length of Stay and Postoperative Opioid Administration in a Same-Day Approach to Breast Reconstruction.
    Kelly BN; Liao EC; Specht MC
    Ann Surg Oncol; 2022 Sep; 29(9):5720. PubMed ID: 35578059
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.
    Nguyen TT; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):693-694. PubMed ID: 30421050
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy.
    Kim WH; Kim HJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):644-645. PubMed ID: 30315382
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time-Highest Rates of Use Now in Triple-Negative and HER2+ Disease.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):695-696. PubMed ID: 30465221
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer.
    Williams AD; Barrio AV
    Ann Surg Oncol; 2022 Dec; 29(13):8012-8013. PubMed ID: 35941345
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Lim DW; Hong NJL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):570-571. PubMed ID: 34435298
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility.
    Newman L
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):683-684. PubMed ID: 30377915
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Kantor O; James TA
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):640-641. PubMed ID: 30302645
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Tailoring of Targeted Axillary Dissection-Intraoperative Nodal Evaluation Reduces Second Operations.
    Wu S; Liu G
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):634-635. PubMed ID: 30411270
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Opioid Prescribing in Surgical Oncology-Institutional Opportunities for Educational Interventions.
    Lillemoe HA; Tzeng CD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):731-732. PubMed ID: 31529310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.